These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28134226)

  • 61. Polish single-centre follow-up of subcutaneous implantable cardioverter-defibrillator (S-ICD) systems implanted for the prevention of sudden cardiac death.
    Kempa M; Budrejko S; Sławiński G; Królak T; Lewicka E; Raczak G
    Kardiol Pol; 2018; 76(2):452-458. PubMed ID: 29350391
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT).
    Bänsch D; Antz M; Boczor S; Volkmer M; Tebbenjohanns J; Seidl K; Block M; Gietzen F; Berger J; Kuck KH
    Circulation; 2002 Mar; 105(12):1453-8. PubMed ID: 11914254
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
    Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
    Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Remote monitoring and follow up of implantable cardioverter defibrillators and cardiac resynchronization therapy devices].
    Guevara-Valdivia ME; Echegaray-Trelles A; Hernández J; Cordero-Pérez Lde J; Valderrama de-León R; Santos MA; Huarte-Hernández Y
    Arch Cardiol Mex; 2011; 81(2):93-9. PubMed ID: 21775242
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Arrhythmic Risk Following Recovery of Left Ventricular Ejection Fraction in Patients with Primary Prevention ICD.
    Berthelot-Richer M; Bonenfant F; Clavel MA; Farand P; Philippon F; Ayala-Paredes F; Essadiqi B; Badra-Verdu MG; Roux JF
    Pacing Clin Electrophysiol; 2016 Jul; 39(7):680-9. PubMed ID: 27062583
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study.
    Dubner S; Valero E; Pesce R; Zuelgaray JG; Mateos JC; Filho SG; Reyes W; Garillo R
    Ann Noninvasive Electrocardiol; 2005 Oct; 10(4):420-8. PubMed ID: 16255752
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term clinical outcome in patients with severe left ventricular dysfunction and an implantable cardioverter-defibrillator after ventricular tachyarrhythmias.
    Pelicano N; Oliveira M; Da Silva N; Antunes E; Santos S; Conceição JM; Roquette J; Quininha J
    Rev Port Cardiol; 2005 Apr; 24(4):487-98. PubMed ID: 15977773
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?
    Gatzoulis KA; Tsiachris D; Dilaveris P; Archontakis S; Arsenos P; Vouliotis A; Sideris S; Trantalis G; Kartsagoulis E; Kallikazaros I; Stefanadis C
    Int J Cardiol; 2013 Aug; 167(4):1360-5. PubMed ID: 22534047
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
    Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
    Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
    Iles L; Pfluger H; Lefkovits L; Butler MJ; Kistler PM; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2011 Feb; 57(7):821-8. PubMed ID: 21310318
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Unscheduled Emergency Visits after Cardiac Devices Implantation: Comparison between Cardioverter Defibrillators and Cardiac Resynchronization Therapy Devices in less than one year of Follow Up.
    Warpechowski Neto S; Ley LLG; Almeida ED; Saffi MAL; Dutra LZ; Ley ALG; Sant'Anna RT; Lima GG; Kalil RAK; Leiria TLL
    Arq Bras Cardiol; 2019 May; 112(5):491-498. PubMed ID: 30810607
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hypertrophic Cardiomyopathy and Implantable Defibrillators in Sweden: Inappropriate Shocks and Complications Requiring Surgery.
    Magnusson P; Gadler F; Liv P; Mörner S
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1088-94. PubMed ID: 26178879
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Trying to predict the unpredictable: Variations in device-based daily monitored diagnostic parameters can predict malignant arrhythmic events in patients undergoing cardiac resynchronization therapy.
    Jędrzejczyk-Patej E; Kowalski O; Sredniawa B; Pruszkowska P; Sokal A; Szulik M; Mazurek M; Kowalczyk J; Kalarus Z; Lenarczyk R
    Cardiol J; 2014; 21(4):405-12. PubMed ID: 24671897
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effectiveness of implantable defibrillators in octogenarians and nonagenarians for primary prevention of sudden cardiac death.
    Mezu U; Adelstein E; Jain S; Saba S
    Am J Cardiol; 2011 Sep; 108(5):718-22. PubMed ID: 21640321
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sudden cardiac death and implantable cardioverter-defibrillators.
    Turakhia MP
    Am Fam Physician; 2010 Dec; 82(11):1357-66. PubMed ID: 21121520
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recurrence of ventricular arrhythmias in patients with non-ischaemic dilated cardiomyopathy: evidence-based predictors.
    Dułak E; Lubiński A; Bissinger A; Przybylski A; Sterlinski M; Filipecki A; Pazdyga A; Zienciuk A; Kempa M; Królak T; Szwed H; Trusz-Gluza M; Kargul W
    Kardiol Pol; 2009 Aug; 67(8):837-44. PubMed ID: 19784881
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Determinants of mortality in patients undergoing cardiac resynchronization therapy: baseline clinical, echocardiographic, and angioscintigraphic evaluation prior to resynchronization.
    de Sisti A; Toussaint JF; Lavergne T; Ollitrault J; Abergel E; Paziaud O; Ait Said M; Sader R; LE Heuzey JY; Guize L
    Pacing Clin Electrophysiol; 2005 Dec; 28(12):1260-70. PubMed ID: 16403157
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: design and first results of the Marburg Cardiomyopathy Study.
    Grimm W; Glaveris C; Hoffmann J; Menz V; Mey N; Born S; Maisch B
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2551-6. PubMed ID: 9825383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.